Patient Education Critical Factor in Successful Tazarotene Use

Moore, Ian J.S.
February 1998
Dermatology Times;Feb98, Vol. 19 Issue 2, p45
Trade Publication
States that tazarotene can be used successfully as a first-line treatment in psoriatic patients when they are properly instructed about its use. Factors to consider in prescribing the drug for psoriasis treatment; Common side effects of psoriatic treatment; How to manage the side effects of psoriatic treatment.


Related Articles

  • Psoriasis: Flaky is only an adjective for piecrusts. Schaefer, Ingrid K. // Dermatology Times;Nov97 Supplement, Vol. 18 Issue 11, pS3 

    Editorial. Contemplates on the advances in psoriasis care. Effectiveness of over-the-counter remedies on psoriasis; Challenge for manufacturers to come up with a more effective treatment for proriasis.

  • FDA okays psoriasis indication for a cyclosporine.  // Dermatology Times;Nov97 Supplement, Vol. 18 Issue 11, pS25 

    Presents highlights of the Neoral labeling related top psoriasis. Considerations before initiating treatment with the drug; Initial recommended dose for patients with psoriasis; Cautions against the use of Neoral for longer than a year.

  • Psoriasis solution. Segell, Michael // Cosmopolitan;Sep95, Vol. 219 Issue 3, p94 

    Suggests a treatment for the skin disease called psoriasis. Estimated number of Americans afflicted with psoriasis; Cause of disease; Experimental therapy that may lead to discovery of drug for disease.

  • A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris. Douglas, W. S.; Poulin, Y.; Decroix, J.; Ortonne, J. P.; Mrowietz, U.; Gulliver, W.; Krogstad, A. L.; Larsen, F. G.; Iglesias, L.; Buckley, C.; Bibby, A. J. // Acta Dermato-Venereologica;Mar2002, Vol. 82 Issue 2, p131 

    In this study, we compared a new combination ointment containing both calcipotriol and betamethasone dipropionate with betamethasone dipropionate ointment (Diprosone[sup ®]) and calcipotriol ointment (Daivonex[sup ®]) in patients with psoriasis vulgaris; 1106 patients were randomized to...

  • Oral Tazarotene. Guttman, Cheryl // Dermatology Times;May2003, Vol. 24 Issue 5, p24 

    Focuses on the use of oral tazarotene in treating psoriasis. Side effects of the drug; Mechanism of action.

  • No Differences. Guttman, Cheryl // Dermatology Times;May2003, Vol. 24 Issue 5, p26 

    Focuses on the use of Alefacept (Amevive) in treating chronic plaque psoriasis. Candidates for systemic therapy or phototherapy; Side effects of the drug; Mechanism of action.

  • PSORIASIS BRIEFS.  // Dermatology Times;May2003, Vol. 24 Issue 5, p27 

    Presents news items related to psoriasis as of May 2003. Effectiveness of Alefacept in treating psoriasis; Promotion of psoriasis drug Donovex.

  • Soriatane Label Revised. Guttman, Cheryl // Dermatology Times;May2003, Vol. 24 Issue 5, p30 

    Focuses on the use of acitretin in treating psoriasis. Effectiveness of the drug; Contraindications; Usage.

  • Quality of life tantamount in Psoriasis therapy. Moyer, Paula // Dermatology Times;Mar1999, Vol. 20 Issue 3, p15 

    States that the degree of treatment of the skin disease psoriasis should depend on how the condition affects the patient's ability to function at home and at home. Variation in the spectrum of severity; Need for the examination of a patient's total body surface; Need to educate patients on the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics